Hitch your wagon to the stock of the future.
Over 60 million PAP smear tests are taken annually.
GTHP developed a biophotonic cervical cancer scan that is noninvasive, more accurate and produces instant test results.
The potential is huge!
60M scans X $15 profit per disposable = $900M
$19,000 per machine
PLUS international sales
Get in on the ground floor.
The new CEO marketing whiz from GE Diagnostics and Abbott Healthcare will make GTHP a market leader.
A $3M order was received from Turkey and dozens of distributors have been signed up.
1 share of ATOS gets you 3 shares of GTHP.
zero.I own GTHP and it has done nothing.
How many message boards are you touting this junk on? Don't you think that if it is as good as you say, it would have some volume?? It's a PENNY stock with no interest!!